In this issue of the Journal, Boink et al.(1) reported the study of biological pacemaker function in mongrel dogs that underwent radiofrequency ablation of the atrioventricular node and were then treated with gene transfer using the hyperpolarization-activated cyclic nucleotide-gated current channel 2 (HCN2) construct, the skeletal muscle sodium channel (SkM1) construct, or the dual (HCN2/SkM1) construct injected into the left bundle branch (LBB) or the left See page 1192 ventricular (LV) subepicardium. The researchers coexpressed SkM1 with HCN2 on the basis of the hypothesis that when HCN2 generated the inward current that would drive the membrane toward threshold, SkM1 would create greater availability of sodium channels during diastole because of a more favorable inactivation curve than the cardiac sodium channel, leading to a more negative threshold potential, improved pacemaker stability, and increased beating rates. Indeed, that is what they found. Five to 7 days after injection, upon stable maximal expression of the HCN2/SkM1 construct, LBB-injected dogs demonstrated higher heart rates (80 to 130 beats/min) and better modulation of pacemaker function during circadian rhythm or epinephrine infusion and did not require electronic pacing backup, compared with LV injected dogs and dogs with LBB injections expressing SkM1 or HCN2 alone (1). The researchers concluded that this model is more biologically suitable for pacing than other constructs reported, findings they attribute to the more negative action potential threshold and injection into the LBB. The actual contribution of each compound was not investigated, and likely some cells expressed HCN2 and others SkM1 in varying relationships and quantities, perhaps depending on how they were infected with one gene or the other. Overall, the functional combination capitalizing on their different and complimentary mechanisms of action was successful, maybe from the averaging effects brought about by the cable properties of a functional cardiac syncytium (2,3).The current report suggested that the expression of HCN2, rather than other isoforms such HCN4, along with SkM1 in the canine LBB, was sufficient to provide an improved automaticity and autonomic responsiveness similar to the highly expressing HCN4 in sinus node pacemaker cells (1). Although cardiac function in LBB-injected dogs appeared to be grossly improved, it remains unclear how exogenous HCN2/SkM1 expression in LBB-injected cells is sufficient to functionally compensate for the difference in anatomic structure and protein expression of LBB cells compared with sinus node pacemaker cardiomyocytes. In addition, further investigation is needed to elucidate whether overexpression of HCN2 in LBB cells leads to the exclusive assembly of functional homotetrameric HCN2 channels or the current observations derived from altered subunit stoichiometry of the existing HCN channels, supporting alternative heterotetrameric HCN channels with intermediate or different activation time constants, steadystate voltage depende...